Relay Therapeutics Inc (RLAY)
4.75
+0.11
(+2.37%)
USD |
NASDAQ |
Nov 22, 16:00
4.74
-0.01
(-0.21%)
After-Hours: 20:00
Relay Therapeutics Price: 4.75 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 4.62 | 4.90 | 4.62 | 4.75 | 3.080M |
Nov 21, 2024 | 4.66 | 4.76 | 4.48 | 4.64 | 1.769M |
Nov 20, 2024 | 4.70 | 4.80 | 4.50 | 4.66 | 2.922M |
Nov 19, 2024 | 4.85 | 4.91 | 4.70 | 4.80 | 1.396M |
Nov 18, 2024 | 5.13 | 5.185 | 4.88 | 4.89 | 1.171M |
Nov 15, 2024 | 5.63 | 5.63 | 5.03 | 5.105 | 1.925M |
Nov 14, 2024 | 5.85 | 5.86 | 5.59 | 5.60 | 901371.0 |
Nov 13, 2024 | 6.00 | 6.10 | 5.81 | 5.81 | 1.390M |
Nov 12, 2024 | 6.07 | 6.18 | 5.905 | 5.94 | 1.141M |
Nov 11, 2024 | 6.32 | 6.39 | 6.10 | 6.16 | 1.128M |
Nov 08, 2024 | 6.15 | 6.31 | 6.055 | 6.20 | 1.225M |
Nov 07, 2024 | 6.33 | 6.48 | 5.96 | 6.14 | 1.840M |
Nov 06, 2024 | 6.30 | 6.50 | 6.001 | 6.25 | 2.125M |
Nov 05, 2024 | 5.78 | 6.00 | 5.66 | 5.95 | 1.050M |
Nov 04, 2024 | 5.78 | 6.035 | 5.65 | 5.85 | 1.323M |
Nov 01, 2024 | 5.69 | 6.00 | 5.63 | 5.84 | 1.259M |
Oct 31, 2024 | 5.71 | 5.755 | 5.60 | 5.635 | 1.022M |
Oct 30, 2024 | 5.85 | 6.09 | 5.695 | 5.71 | 1.029M |
Oct 29, 2024 | 6.00 | 6.15 | 5.77 | 5.90 | 1.108M |
Oct 28, 2024 | 6.06 | 6.17 | 5.93 | 6.03 | 2.589M |
Oct 25, 2024 | 6.22 | 6.380 | 6.00 | 6.02 | 862711.0 |
Oct 24, 2024 | 6.35 | 6.41 | 6.02 | 6.19 | 1.081M |
Oct 23, 2024 | 6.59 | 6.645 | 6.20 | 6.30 | 1.172M |
Oct 22, 2024 | 6.35 | 6.69 | 6.34 | 6.66 | 980955.0 |
Oct 21, 2024 | 6.68 | 6.77 | 6.42 | 6.43 | 904305.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.64
Minimum
Nov 21 2024
61.53
Maximum
Jan 22 2021
21.97
Average
19.84
Median
Price Benchmarks
Pfizer Inc | 25.65 |
Summit Therapeutics Inc | 19.00 |
Biomarin Pharmaceutical Inc | 64.26 |
Lexicon Pharmaceuticals Inc | 0.8634 |
Arbutus Biopharma Corp | 3.51 |
Price Related Metrics
PS Ratio | 17.77 |
Price to Book Value | 0.9478 |
Earnings Yield | -54.95% |
Market Cap | 795.07M |